Xconomy: National top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More	Alex Lash	09/20/19	National
Amazon Sets Electric Vehicle, Carbon Footprint Goals Amid Criticism	Jeff Buchanan	09/19/19	Seattle
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?	Alex Lash	09/19/19	National
New Deals May Double $240M Funding For MIT-IBM AI Lab, Director Says	Brian Dowling	09/19/19	Boston
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M	Sarah de Crescenzo	09/19/19	San Diego
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market	Mike Ward	09/16/19	National
Why Menlo Ventures Backed Construction Tech Firm Fieldwire	Bernadette Tansey	09/16/19	San Francisco
Cloudflare’s $525M IPO Emboldens Already-Confident Internet Booster	David Holley	09/13/19	San Francisco
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More	Ben Fidler	09/13/19	National
Booming CS Demand Brings Ex-Acquia CEO Back to His UW Roots	Jeff Bauter Engel	09/13/19	Wisconsin
The Winners of the 2019 Xconomy Awards Boston Are…	Jeff Bauter Engel	09/12/19	Boston
John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22	Jeff Bauter Engel	09/12/19	Boston
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb	Frank Vinluan	09/11/19	San Francisco
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17	Ben Fidler	09/11/19	Boston
After First Look at House Drug Plan, Stocks Rise Slightly	Alex Lash	09/10/19	National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards	Ben Fidler	09/10/19	National
Shopify Buys 6 River Systems for $450M to Boost Fulfillment Centers	Brian Dowling	09/10/19	Boston
Amazon, With More WA Workers than Microsoft, Eyes Adding 10K More	Jeff Buchanan	09/09/19	Seattle
Epstein Fallout: Joi Ito Resigns From MIT Media Lab, Multiple Boards	Brian Dowling	09/09/19	Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More	Ben Fidler	09/09/19	National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone	Frank Vinluan	09/06/19	National
Bankrupt uBiome Says Founders May Have Misled Investors	Alex Lash	09/04/19	San Francisco
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes	Frank Vinluan	09/03/19	Boston
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss	Ben Fidler	09/03/19	Boston
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing	Ben Fidler	09/02/19	New York
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer.	David Holley	08/30/19	Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More	Alex Lash	08/30/19	National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop	Ben Fidler	08/29/19	Detroit Ann Arbor
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation	Bernadette Tansey	08/28/19	San Francisco
NuTonomy Switches to Chrysler For More Elbow Room in Self-Driving Cars	Brian Dowling	08/27/19	Boston
Page 1 of 233	next page »